226 related articles for article (PubMed ID: 31074727)
1. The influence of immunosuppressants on the non-melanoma skin cancer among patients with systemic lupus erythematosus and primary Sjögren's syndrome: a nationwide retrospective case-control study in Taiwan.
Tseng HW; Huang WC; Lu LY
Clin Exp Rheumatol; 2019; 37(6):946-952. PubMed ID: 31074727
[TBL] [Abstract][Full Text] [Related]
2. The influence of disease-modifying anti-rheumatic drugs and corticosteroids on the association between rheumatoid arthritis and skin cancer: a nationwide retrospective case-control study in Taiwan.
Tseng HW; Lu LY; Lam HC; Tsai KW; Huang WC; Shiue YL
Clin Exp Rheumatol; 2018; 36(3):471-478. PubMed ID: 29303707
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppressive medication use and risk of herpes zoster (HZ) in patients with systemic lupus erythematosus (SLE): A nationwide case-control study.
Hu SC; Yen FL; Wang TN; Lin YC; Lin CL; Chen GS
J Am Acad Dermatol; 2016 Jul; 75(1):49-58. PubMed ID: 26946984
[TBL] [Abstract][Full Text] [Related]
4. The association between hydroxychloroquine use and future development of systemic lupus erythematosus in patients with primary Sjögren's syndrome.
Hsu BC; Chen YH; Lin CH; Tang KT
Int J Rheum Dis; 2022 Dec; 25(12):1424-1430. PubMed ID: 36089698
[TBL] [Abstract][Full Text] [Related]
5. Evidence for the Detection of Subclinical Retinal Involvement in Systemic Lupus Erythematosus and Sjögren Syndrome: A Potential Association with Therapies.
Conigliaro P; Triggianese P; Draghessi G; Canofari C; Aloe G; Chimenti MS; Valeri C; Nucci C; Perricone R; Cesareo M
Int Arch Allergy Immunol; 2018; 177(1):45-56. PubMed ID: 29902805
[TBL] [Abstract][Full Text] [Related]
6. Primary Sjogren's syndrome and the risk of acute pancreatitis: a nationwide cohort study.
Chang CC; Chang YS; Wang SH; Lin SY; Chen YH; Chen JH
BMJ Open; 2017 Aug; 7(8):e014807. PubMed ID: 28801391
[TBL] [Abstract][Full Text] [Related]
7. Cumulative immunosuppressant exposure is associated with diversified cancer risk among 14 832 patients with systemic lupus erythematosus: a nested case-control study.
Hsu CY; Lin MS; Su YJ; Cheng TT; Lin YS; Chen YC; Chiu WC; Chen TH
Rheumatology (Oxford); 2017 Apr; 56(4):620-628. PubMed ID: 28039419
[TBL] [Abstract][Full Text] [Related]
8. Risk of Sjögren's syndrome in Taiwanese female adults with irregular menstrual cycles: a population-based case-control study.
Lu MC; Hsieh MC; Koo M; Lai NS
Rheumatol Int; 2016 Jan; 36(1):155-60. PubMed ID: 26194149
[TBL] [Abstract][Full Text] [Related]
9. Prevalence, incidence, and associated factors of avascular necrosis in Korean patients with systemic lupus erythematosus: a nationwide epidemiologic study.
Joo YB; Sung YK; Shim JS; Kim JH; Lee EK; Lee HS; Bae SC
Rheumatol Int; 2015 May; 35(5):879-86. PubMed ID: 25300729
[TBL] [Abstract][Full Text] [Related]
10. Corticosteroid dose and the risk of opportunistic infection in a national systemic lupus erythematosus cohort.
Yang SC; Lai YY; Huang MC; Tsai CS; Wang JL
Lupus; 2018 Oct; 27(11):1819-1827. PubMed ID: 30103646
[TBL] [Abstract][Full Text] [Related]
11. Hydroxychloroquine may reduce risk of Pneumocystis pneumonia in lupus patients: a Nationwide, population-based case-control study.
Yeo KJ; Chen HH; Chen YM; Lin CH; Chen DY; Lai CM; Chao WC
BMC Infect Dis; 2020 Feb; 20(1):112. PubMed ID: 32041539
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effect of cumulative corticosteroid dose and immunosuppressants on avascular necrosis in patients with systemic lupus erythematosus.
Kwon HH; Bang SY; Won S; Park Y; Yi JH; Joo YB; Lee HS; Bae SC
Lupus; 2018 Sep; 27(10):1644-1651. PubMed ID: 29950160
[TBL] [Abstract][Full Text] [Related]
13. [Drug-induced Sweet's syndrome related to hydroxychloroquine: About 2 cases].
Bodard Q; Carre D; Chenal P; Zarnitsky C; Midhat M; Litrowski N
Rev Med Interne; 2020 Apr; 41(4):289-292. PubMed ID: 31540835
[TBL] [Abstract][Full Text] [Related]
14. Hydroxychloroquine Does Not Increase the Risk of Cardiac Arrhythmia in Common Rheumatic Diseases: A Nationwide Population-Based Cohort Study.
Lo CH; Wei JC; Wang YH; Tsai CF; Chan KC; Li LC; Lo TH; Su CH
Front Immunol; 2021; 12():631869. PubMed ID: 33868251
[TBL] [Abstract][Full Text] [Related]
15. Targetoid-like Lesions in the Setting of Systemic Lupus Erythematosus: A Case of Rowell Syndrome.
Ward JM; Hess JN; Davis LS
J Rheumatol; 2020 Feb; 47(2):298-299. PubMed ID: 32007943
[No Abstract] [Full Text] [Related]
16. Longitudinal Treatment Patterns and Associated Outcomes in Patients With Newly Diagnosed Systemic Lupus Erythematosus.
Kan H; Nagar S; Patel J; Wallace DJ; Molta C; Chang DJ
Clin Ther; 2016 Mar; 38(3):610-24. PubMed ID: 26907503
[TBL] [Abstract][Full Text] [Related]
17. Increased risk of primary Sjögren's syndrome in female patients with thyroid disorders: a longitudinal population-based study in Taiwan.
Lu MC; Yin WY; Tsai TY; Koo M; Lai NS
PLoS One; 2013; 8(10):e77210. PubMed ID: 24204772
[TBL] [Abstract][Full Text] [Related]
18. Primary Sjögren's syndrome.
Bowman SJ
Lupus; 2018 Oct; 27(1_suppl):32-35. PubMed ID: 30452329
[TBL] [Abstract][Full Text] [Related]
19. Hydroxychloroquine reduces risk of incident diabetes mellitus in lupus patients in a dose-dependent manner: a population-based cohort study.
Chen YM; Lin CH; Lan TH; Chen HH; Chang SN; Chen YH; Wang JS; Hung WT; Lan JL; Chen DY
Rheumatology (Oxford); 2015 Jul; 54(7):1244-9. PubMed ID: 25587177
[TBL] [Abstract][Full Text] [Related]
20. Risk and severity of herpes zoster in patients with rheumatoid arthritis receiving different immunosuppressive medications: a case-control study in Asia.
Liao TL; Chen YM; Liu HJ; Chen DY
BMJ Open; 2017 Jan; 7(1):e014032. PubMed ID: 28057661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
